MARÍA LUISA
NAVARRO GÓMEZ
Profesora asociada
Maria Angeles
Muñoz Fernandez
2025
-
Health-related quality of life in people with HIV from the multicentre CoRIS cohort in Spain: Associated factors and short-term changes over time
HIV Medicine, Vol. 26, Núm. 4, pp. 606-620
-
Increased mortality and morbidity risk in people with early HIV care interruption in Spain
AIDS, Vol. 39, Núm. 9, pp. 1224-1234
-
Real-world Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Comparison With Other Regimens in People With Human Immunodeficiency Virus Starting Therapy With AIDS-Defining Conditions: Results From the CoRIS Cohort - The ACTUAS II Study
Clinical Infectious Diseases
-
Should we measure quality of life among people with HIV? A multicentre survey of physicians' opinions in Spain
HIV Medicine, Vol. 26, Núm. 2, pp. 308-318
2024
-
Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain
AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314
-
Changes in bodyweight after initiating antiretroviral therapy close to HIV-1 seroconversion: an international cohort collaboration
The Lancet HIV, Vol. 11, Núm. 10, pp. e660-e669
-
IgG antibody levels against the SARS-CoV-2 spike protein in mother–child dyads after COVID-19 vaccination
Infection, Vol. 52, Núm. 3, pp. 813-824
2023
-
Antibody levels to SARS-CoV-2 spike protein in mothers and children from delivery to six months later
Birth, Vol. 50, Núm. 2, pp. 418-427
-
Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV – Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial
eClinicalMedicine, Vol. 60
2022
-
Impact of Gestational COVID-19 on Neonatal Outcomes: Is Vertical Infection Possible?
The Pediatric infectious disease journal, Vol. 41, Núm. 6, pp. 466-472
-
Nutritional Supplementation to Increase Influenza Vaccine Response in Children Living With HIV: A Pilot Clinical Trial
Frontiers in Pediatrics, Vol. 10
-
Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort
HIV Medicine, Vol. 23, Núm. 8, pp. 825-836
-
Risk-score based strategy to minimize antibiotic exposure in children with sickle cell disease and fever
Infection, Vol. 50, Núm. 2, pp. 499-505
-
Targeting the Gut Microbiota of Vertically HIV-Infected Children to Decrease Inflammation and Immunoactivation: A Pilot Clinical Trial
Nutrients, Vol. 14, Núm. 5
2021
-
COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study
HIV Medicine, Vol. 22, Núm. 9, pp. 867-876
-
Innate and adaptive abnormalities in youth with vertically acquired HIV through a multicentre cohort in Spain
Journal of the International AIDS Society, Vol. 24, Núm. 10
-
Interleukin 6 as a marker of severe bacterial infection in children with sickle cell disease and fever: a case–control study
BMC Infectious Diseases, Vol. 21, Núm. 1
-
The clinical relevance of the microbiome when managing paediatric infectious diseases—Narrative review
Acta Paediatrica, International Journal of Paediatrics, Vol. 110, Núm. 2, pp. 441-449
2020
-
Effect of a Nutritional Intervention on the Intestinal Microbiota of Vertically HIV-Infected Children: The Pediabiota Study
Nutrients, Vol. 12, Núm. 7
-
Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: A multicentre cohort study
AIDS Research and Therapy, Vol. 17, Núm. 1